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Abstract 
       This study was amid to investigate the existence of HBV and the diagnosis of 
autoimmune hepatitis (AIH) in addition study (C3, C4) Levels among chronic hepatitis B 
patients. The current study was conducted on 360 patients suspected with hepatitis B virus 
infection, which have age ranging (11-72) year were collected from center health laboratory, 
AL-Hakeem hospital, and AL-Sadder medical city in AL-Najaf city, during the period from 
January (2013) to August (2013). Fifteen healthy individuals without any evidence of chronic 
inflammatory disease involved as control, age ranging (21-50) years. The results showed  that 
only 76 were  seropositive hepatitis B in ELISA technique , the age group (44-54) year 
revealed high significance(p<0.05) than other age groups. While 35 (46%) out of 76 
seropositive with HBc Ab, the age group (55-65) year showed high significant (p<0.05) than 
other age groups, and male more infection than female. The result also revealed that the 
autoimmune hepatitis disease was 5 (6.5%) out of 76 patient infected with Type 1autoimmune 
hepatitis. Complement fractions C3, decreased in all patients compared to those of a healthy 
control, while the autoimmune hepatitis patient recorded high level was 142.2±8 mg/dI. In 
regard to C4 was revealed normal concentration in all patients compared with control groups 
while the autoimmune hepatitis patient recorded high level was 41.7±5.1 mg/dI and non-
significant (P<0.0) in males than female in concentration of (C3 and C4). 
 
Introduction 
         Hepatitis B virus is one of the most common infectious diseases globally.  It is  a  major  
public  health problem  accounting  to  400  million  chronic  infections  worldwide. About 2 
billion people (or 30% of world population) worldwide have serological evidence of current 
or past HBV infection, of whom about one million die annually (Lindenberg et al., 2013; Daw 
et al., 2014; Mehta et al., 2014 ; Salih, 2014). 
        Iraq is a developing country, where HBV virus infections are still prevalent, with an 
HBV carrier rate of 2%–5%. Although Iraq depended the HBV vaccination in its expanded 
programmer on Immunization, the coverage rate is less than 80%. Hospital-acquired HBV 
infections continue to occur despite increased awareness of the problem among the medical 
community (Al-Jadiry et al., 2013). 
Autoimmune hepatitis (AIH) is a progressive, chronic inflammatory liver disease of unknown 
etiology that occurs in children and adults with a prevalence of female. This clinical 
syndrome is caused by an immune response that is misdirected against self or foreign antigens 
that resemble self-antigens, leading to a progressive inflammatory and fibrotic process of the 
liver (Manns and Vogel, 2006; Czaja, 2007a; Czaja 2007b;Vergani and Mieli-Vergani, 2008). 
The complications of AIH are the same as any other progressive liver disease. Primary 
hepatocellular carcinoma is a known consequence; in some patients, chronic hepatitis 
progresses to cirrhosis and, ultimately, to carcinoma. Liver transplantation is required when 
end stage liver disease develops (Krawitt, 2006; Pierpaolo  et al., 2012).The humeral immune 
responses were mediated by specific antibodies that recognize and react to any challenges, as 
well as by complement components, so estimation of serum immunoglobulin and complement 
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may provide a useful marker for disease progression and therapeutic monitoring (Ahmad et 
al., 2014). 
 
Materials and Methods 
      All samples were collected from AL-Hakeem hospital (center laboratory) and AL-Sadder 
medical city in AL-Najaf city, during the period from January (2013) to August 
(2013).Fifteen apparently healthy individuals were selected as normal control groups in this 
study. Approximately (5 ml) of fresh blood was drawn from each patient by vein puncture, 
collected in tubes were without anti-coagulant as plain tubes thereafter they were centrifuged 
for 5 minutes at 3000 (rpm) to separate serum, The serum samples were liquated in sterile test 
tubes using micropipette with sterile disposable tips to  use  for subsequent serological tests. 
Each sample was labeled and given a serial number together with the patient name, the serum 
samples were frozen at (-20°C)  (Lewis, et al., 2006) . Until used investigation included: 
Virological diagnostic and immunological investigations.  
Detection of HBsAg in human serum by ELISA technique (Dialab-Austria Kit)  
A- Assay Procedure 
      The test was performed according to restrictions manual of manufacturing company   as 
following: 
1- The washing buffer was diluted with distilled water Relation (1:20). 
2-The samples and reagents were brought to room temperature.  
3- Before commencing the assay.     
4- For each test, one blank, two positive and three negative controls were set,  then  50μl of 
positive and negative control serum  were added into positive and negative control wells 
respectively. 
5- A50μl of sample were added into each test well. 
6-The wells covered with the seal paper and incubated for 60 minutes at 37˚C. 
7- By using of ELISA washer, ELISA System EL 800, the liquid in all wells discarded and 
filled with   300 μl per well of the washing solution, laid aside For 30-60 seconds and 
discarded of the liquid in all wells which than filled with wash solution. Repeat 5 times and 
dry wells after last wash                               
8- Dispensed 50µl of substrate solution B and substrate solution A into each well respectively, 
mixed gently, protected from light and incubated for 15 minutes at 
37
º
C.                                                                                                   
9- Stopping solution in amount of 50 μl were added into each well and mixed gently to stop 
the   reaction including blank well.                                                                                                
    
10- The Optical Density (O.D.) was read at wave length 450 nm using a Micro well system 
reader ELISA reader within 5 minutes after stopped the reaction 
B. Interpretation of the Results: 
Cut off Value (COV) was calculated as following: 
COV = 2.1× the average OD of negative controls. 
Positive sample at whichOD450 of the sample ≥ COV. 
Negative sample at whichtheOD450 of the sample ＜COV. 
 
Detection of HBc Ab in Human Serum by ELISA technique (Foresight-USA Kit). 
A-Assay Procedure 
1- Prepared working wash buffer by diluting the concentrated wash buffer 1:25. 
2- Leaved A1 as blank well. 
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3- A50 µl positive controls were added to B1 and C1. 
4- A50 µl negative controls were added to D1 and E.  
5- Starting F1: added 50 µl specimen. 
6- Added 50 µl of conjugate to each well except for the blank well. 
7- Mixed gently. 
8- Covered the microwell plate with plate sealer and incubated at 37 ºC for 30 minutes. 
9- Removed the plate sealer. 
10- Washed each well 5 times with 350 µl of working wash buffer. 
11- Turned the microwell plate upside down on absorbent tissue. 
12- Added 50 µl of substrate A to each well. (Clear reagent) 
13- Added 50 µl of substrate B to each well. (Clear reagent)  
14- Mixed gently then covered microwell pate with plate sealer and incubated in a water bath 
or incubator at 37 ºC ± 2 ºC for 15 minutes ± 1minute. 
15- Removed the plate sealer.  
16- Added 50 µl of stop solution to each well. 
17- Read at 450/630-700 nm within 30 minutes. 
 
B. Interpretation of the Results 
Cut off Value (COV) was calculated as following: 
  COV = 0.2× NCx 
NCx=Mean Absorbance of Negative Control-Blank Absorbance 
Negative Control= Mean Absorbance after subtraction of Blank Absorbance should b≥ 1.000 
Positive Control= Mean Absorbance after subtraction of Blank Absorbance should be< 0.080 
 
Detection of Autoimmune Liver Diseases  
A-Assay Procedure: 
1- The samples and reagents were brought to room temperature before commencing the assay. 
2- Wash Buffer to be diluted 1part (wash 20x) with 19 parts distilled water. 
3-About 30 ml of wash added to buffer (RCNS 30 ml) and mixed well. This solution was 
called Buffer Solution (DIL). 
4-The sample diluted by added 10μl serum to 1ml DIL. 
5- The strips put into the incubation tray and moist in 1ml (DIL) to wet the membrane. And 
then removed (DIL) after 1 min. 
6- 1ml of diluted patient sample was transferred into each strip of the incubation tray, and 
incubated for 30 min at room temperature with gentle agitation. 
7- Removed diluted sample completely. 
8- Washed strip 3 times used 1.5 ml wash for 5 min.with gentle agitation. 
9- Removed wash after ever washing step. 
10-1ml of conjugate Solution was transferred into each strip of the incubation tray, and 
incubated for 30 min at room temperature with gentle agitation. 
11- Removed conjugate solution. 
12- Washed strip 3 times used 1.5 ml wash for 5 min.with gentle agitation, and removed wash 
after ever washing step. 
13- 1 ml of TMB LIA solution (SUB) were added to each strip, and incubated for 10 min at 
room temperature with gentle agitation. 
14- Removed TMB LIA solution (SUB). 
15- Washed with 1.5 ml distilled water (with gentle agitation). 
16- Removed distilled water after 1min. 
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17- Pipette 1 ml of Stop LIA Solution into all strips, and incubated developed strip for 5 min. 
with gentle agitation to terminate the enzymatic reaction. 
18-Dried strip between filter paper. 
 
 D- Interpretation of the Results: 
      Fixed strip onto scored sheet and aligned the reference line of the strip with the reference 
line on the score sheet. 
Aligned the dotted reference line of the evaluated template with the reference line of the strip. 
The Interpreted of the test Results taken place exclusively on basis of the respective cut-off 
control regarded for each strip: 
The test result was negative, if no band was recognized or if the band exhibited a smaller 
intensity in compared to the cut-off control. 
The test was equivocal, if the intensity of the band and the intensity of the cut-off control did 
not significantly differ. 
The test result was positive, if a band exhibit a strong stain in compared to the cut-off control 
 A normal test indicated by a visible function control. 
 The cut-off control was visible. 
 Intensity function control was > Intensity cut-off control 
 The evaluated template with the reference line of the strip was showing in  
 following Figer(1) 
 
Figer (1): The evaluated template with the reference line of the strip (Human, Germany). 
 
Complement (C3) and (C4): 
      The Determination of the (C3 and C4) protein by (RID) radial immunodiffusion plate was 
performed according to the manufacturing company (LTA s. r. l, Italy) as follows:  
A- Reagents for C3 Complement: 
Plate of Agarose gel containing the goat antiserum C3. 
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B- Reagents for C4 Complement: 
Plate of Agarose gel containing the goat antiserum C4. 
C-Procedure According to manufacturer Company: 
1- The plate was removed from its envelope and leaved at room temperature for few minutes, 
for the any condensed water in the well evaporated. 
2-5µl of sample and controls was filled the wells and waited to completely adsorbed before 
handed the plate. 
3- The plate was closed and placed it in a moist chamber. Then incubated for (72 hours). 
D-Results Interpretation: 
     The concentration value corresponding to the precipitating ring diameter was read on 
enclosed reference table, for each complement (C3 and C4). 
Statistical Analysis 
     Data were translated into a computerized database structure. An expert statistical advice 
was sought for. Statistical analyses were computer assisted using SPSS version 17 (Statistical 
Package for Social Sciences). Frequency distribution for selected variables was done first. 
Standard error (SE) and the parametric statistical tests of significance was applied T test. One 
way ANOVA test model and LSD test at level of significance p< 0.05 were applied to 
estimate the significant differences in viral loads between study groups (Al-Rawi and Khalaf 
Allah, 2000).                                                                          
 
Results 
Detection of HBsAg by ELISA technique 
      The results revealed high significance (p < 0.05 ) in the specific anti-HBsAg in all patients 
compared with negative control while the group with aged (44-54) year recorded the highest 
mean level (2.334 IU/ml) compared with other patients  shown in the (Table 1). 
 
Table (1): The Levels of HBsAg IU/ml among patients 
 
Age group 
(year) 
 
Numbe
r  
anti - 
HBsAg 
positive 
mean level of 
negative control 
mean level of 
positive control 
mean level of 
positive sample 
11-21 9 9 0.070 2.237 2.076 
22-32 19 19 0.070 2.237 2.210 
33-43 19 19 0.070 2.237 2.304 
44-54 14 14 0.070 2.237 2.334 
55-65 12 12 0.070 2.237 2.185 
> 65 3 3 0.070 2.237 2.165 
Total 76 76    
  LSD=0.223      
Detection of chronic hepatitis patients HBc Ab 
 
     The patients with HBsAg showed percent of infectivity with HBc Ab included 35(46 %) 
patients With age ranging (11-72) years old , all patients with HBc Ab revealed high mean 
level (p<0.05) compared with negative control while patients with aged (55-65) recorded high 
mean level  (0.206) compared with other patients as in (Table 6). In the samples taken from 
all patients with HBc Ab infection, it had been shown that consisted of 25(32.8%) males and 
10(13.1%) female Table (2). 
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Table (2): The level of anti-HBc Ab IU/ml in patients by ELISA technique 
  LSD=0.092    
Detection of Autoimmune hepatitis 
     The percentage of Type 1 autoimmune hepatitis diseases was 5(6.57%) out of 76 patients 
consisted of three male and two female with age ranged 35-72 years old.  As in (Table 3) and 
Figure (2)            
  
 Table (3): characteristics of autoimmune hepatitis patients 
Age of patients 
year 
males females 
Anti 
HBsAg+ 
Anti 
HBc 
Ab+ 
autoimmune 
hepatitis 
Type of 
autoimmune 
hepatitis 
35 - 1 + + + Sp100 
50 1 - + + + Sp100 
60 1 - + + + Sp100 and 
Am Am2 
65 1 - + + + Sp100 
72 - 1 + + + Sp100 
 
mean of the 
titer of 
positive 
sample 
mean of the 
titer of 
positive 
control 
mean of the 
titer of 
negative 
control 
HBc  Ab 
positive 
anti-
HBsAg 
positive 
 
Number 
 
Age 
groups 
(year) 
0.168  0.016 0.575 4 9 9 11-21 
0.067  0.016 0.575 6 19 19 22-32 
0.077 0.016 0.575 7 19 19 33-43 
0.099 0.016 0.575 8 14 14 44-54 
0.206 0.016 0.575 8 12 12 55-65 
0.196 0.016 0.575 2 3 3 >65 
   35 76 76 total 
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 A 
                        -A- -B- 
Figure (2): Immune Assay (LIA) for the Detection of Autoimmune hepatitis. 
A- Positive Autoimmune hepatitis type1 (SP100). B- Negative   
Complement detection (C3 & C4) 
     The results demonstrated low significance in (C3) level in all patients groups compared 
with their control (140.5 ±13.9 mg/dI).While significance increase in autoimmune hepatitis to 
(142.2±8.5) mg/dI .The results showed normal concentration of C4 level in patients with 
HBsAg and HBc Ab compared with control group while the level of C4 in Autoimmune 
revealed high significant were (41.7±5.1) compared with control group (30.5 ±2.4) as 
in(Table4). 
 
Table (4): The Level of C3 & C4 mg/dI among patient groups in comparison to healthy 
control.  
LSD Autoimmune 
M ± SE 
HBc Ab 
M ± SE 
HBsAg 
M ± SE 
control 
M ± SE 
Complement 
LSD=1.6                
 
142.2      
±8.5 
136.8 
±5.7 
140.0 
±5.4 
141.5 
±13.9 
C3 
mg/dI 
 
LSD=3.3 
 
41.7 
±5.1 
29.3 
±2.6 
31.8 
±1.9 
30.5 
±2.4 
C4 
mg/dI 
 
Complement detection with sex 
      The concentration of C3 was significant decrease at (p >0.05) in both sexes compared with 
control group figure (3). The concentration of C4 showed no-significance difference between 
female and male, while male increased significant compared with their control figure (4). 
 
  
Al-Kufa University Journal for Biology / VOL.8/ NO.2/ Year: 2016 
6544-ISSN: 2311 8854 & Online-ISSN: 2073 Print  
 
 
RL: http://www.uokufa.edu.iq/journals/index.php/ajb/index                       
http://iasj.net/iasj?func=issues&jId=129&uiLanguage=                                                                                   
Email: biomgzn.sci@uokufa.edu.iq1Enjoy My Fine Releases. 
29 
 
 
 
Figure (3): Level of C3 in all patients groups according to sex compared with healthy control 
group. 
 
Figure (4): Level of C4 in all patients groups according to sex compared with healthy control 
group 
Discussion 
The age distribution 
      The present study according to age distribution was adopted the anti-HBsAg is global 
marker of infection with HBV revealed that significant increase at  (p < 0.05 ) in the specific 
anti-HBsAg in all patients  while the age groups (44-54) year old were the highest 
significance in mean level(2.334 IU/ml) compared with other patients (Table 1) .These data 
were closer to study by Daw et al., (2000) in Libya that appeared the largest group between 
30 to 45 years, and the results of present study is similar to results Khan et al.,(2011) in 
Pakistan that showed the highest frequency of infection  was found in the age of 21-30 was 
34.93%  followed by 23.83% in 31-40 only 13.39% were belonging to the age group 11-20 
years and agree with recent study in Iraq that revealed the higher prevalence of hepatitis B 
among young aging groups (31-40) and (41-50) years compared to older age groups Abdul-
Husin, (2013).                                                                             
     In table (2) shows the distribution of chronic HBV patients according to age .It has been 
found that age (55-65) year recorded high mean titer (0.206) compared with other patients 
.The results of the present study were similar to those done in California by Brown et al., 
(2013) who found that the chronic HBV infection were among persons aged 25-54 years, less 
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than 18 years age had the lowest rate of chronic HBV infection. The results of the present 
work  agrees with other study  Machado etal., (2013) that revealed the prevalence of positive 
anti-HBC was 23% among the elderly which is significantly higher than that found for 
younger individuals.                                                                      
 
The Sex influence 
     The results showed that the prevalence of acute HBV infection in males 55(72%) higher 
than females, There is a high similarity between this results and previous work in Iraq by AL-
Khozai, (2006); AL-Saidi, (2012) that the males are more affected with HBV than females, 
also several studies in the world agreed with this study results as Baig, (2009) who reported 
the frequency of hepatic infection in males was 79.5%and in females 20.5%.                                                                                             
    These results are comparable with other results reported a high prevalence of HBV 
infection. Moosa et al, (2009); Awan et al, (2010) reported a high (59.1%, 58.3%) prevalence 
in males than females (40.9%, 41.7%) respectively. These results accordance with a Pakistan 
study in which male were found to be  more frequently infected  with HBV as compared to 
female with a positivity ratio of 2.14:1.0 respectively. The rate of infection in both male and 
female tends to increase with the passage of time. The highest rates of infection 44.54% were 
0 followed by 30.13% 2009 and 25.32% in 2008 respectively (Khan etal, 2011). Also this fact 
is well documented by (Blumberg, 2006) that higher anti-HBsAg seroprevalence has been 
reported in male than in female for populations in some Asia country.                                                                                                                                                         
     The study under discussion agrees with other study that has revealed the chronic HBV 
infection was 2.9 times more frequent in males than in females Kursad et al., (2005); 
Alexander and Kourtis, (2007) found that men predominate women in all populations of 
HBsAg carriers. The gender is well established but poorly understood, determinant of 
chronicity; however women are more likely than men to clear HBsAg
   
( David and Daniel, 
2003).  Higher HBV Infection in males as compared to female may be due their being 
employed outsides their homes, visiting barber shops and also their involvement in blood 
transfusion practices. While women are mostly involved in house hold activates based on the 
social, cultural and religious preferences and influence. Qureshi et al., (2009); Khan et al., 
(2011). 
   
Detection of Autoimmune hepatitis 
     The current study Showed that the proportion of Type 1 Autoimmune hepatitis diseases 
5(6.57%) out of 76 patients, consisted of three male and two female with age ranged 35-72 
years old.  as in (Table 3) The results of the presented study in agreement with Manns et al., 
(2010) who founds Type 1 can occur at any age; however, it most often starts in adolescence 
or young adulthood .About 70 percent of people with Type 1 autoimmune hepatitis are female 
.Type 2 autoimmune hepatitis is less common and occurs more often in children than adults.         
Krawitt, 2006; Manns and Vogel, 2006) demonstrated that the Autoimmune hepatitis (AIH) is 
a progressive, chronic inflammatory liver disease of unknown etiology that occurs in children 
and adults with a prevalence of female. This clinical syndrome is caused by an immune 
response that is misdirected against self or foreign antigens that resemble self-antigens, 
leading to a progressive inflammatory and fibrotic process of the liver the complications of 
AIH are the same as any other progressive liver disease. Primary hepatocellular carcinoma is 
a known consequence; in some patients, chronic hepatitis progresses to cirrhosis and, 
ultimately, to carcinoma. Liver transplantation is required when end stage liver disease 
develops.                                         
      Distribution of autoimmune disease among hepatitis B and coinfection hepatitis B with 
cytomegalovirus HCMV Can be explained by five main mechanisms through which an 
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infector can contribute to the pathogenesis of an autoimmune disease (Wucherpfennig, 2001; 
Barzilai et al., 2007) first is molecular mimicry, where the infecting agent may incorporate an 
epitope that is structurally similar to a self-antigen. This structural resemblance confuses the 
immune system and induces the autoimmune response. Another mechanism is a phenomenon 
known as epitope spreading, where an exaggerated local activation of antigen presenting Cells 
due to an inflammatory state may cause over processing and over presentation of antigens. In 
chronic autoimmune disease, this exaggerated Activation may cause the priming of large 
numbers of T cells with broad specificities, thus encouraging the development of the 
autoimmune disease. Viral and bacterial super antigens possess the ability to bind to the 
variable Domain of the T cell receptor beta chain along with the ability to bind to a wide 
variety of MHC class 2 molecules. These capabilities allow them to bind to awide variety of T 
cells, irrespective of their specificity and to therefore induce an autoimmune reaction. 
Bystander activation is a mechanism describing a situation where enhanced cytokine 
production induces the expansion of autoreactive T cells whose prior number was insufficient 
to produce an overt disease. The last mechanism is known as polyclonal activation or 
activation of lymphocytes by lymphotrophic viruses. In this case, an infection of B cells 
results in B cell proliferation, enhanced antibody production, and the generation of circulating 
immune complexes that may cause damage to self-tissues.(Ferri and Zignego,2000 ;Varani 
and landini,2011). 
      In present study it has been found that  autoimmune hepatitis was 3(60%) in male and 
2(40%) in female, while studies from some researchers show that autoimmune hepatitis in 
female to male ratio ranges from 3:1,in type 1, to 9:1, in type 2 AIH. Sex differences in the 
immune response are also observed in other liver diseases, men are more likely to become 
chronic carriers of hepatitis B than women Alvarez et al., (2001).  Another study conducted 
by Oo et al., (2010); Toyoda-Akui et al, (2011) stated that the rate of autoimmune hepatitis 
was more common in females (70%) and it affects all age.                                                                                       
     Several studies have investigated the effect of donor: recipient sex matching in the 
outcome of orthotropic liver transplantation (OLT) and have found that male to female grafts 
have the most, and female to male the least favorable.  This gender discrepancy could be the 
result of existing differences in basic immune responses between females and males, higher 
levels of antibodies and stronger T cell activation are observed in women after vaccination 
Women have higher absolute numbers of CD4+ T-cells and produce higher levels of Th1 
cytokines than men. Interestingly, in vitro Oestrogen increases Th1 cytokine production by 
Tlymphocytes, while a decrease is observed in presence of androgen. (Béland et al., 2009).                                          
 
Complement levels (C3 and C4) 
      
     In the present study, C3 level showed a significant decrease in all  patients .the results 
recorded no significant difference (p< 0.05) between male and female in serum level (C3) in 
all patients Figure (3) While the results of C4 level was normal in all patients as compared to 
healthy controls group as in  Table (4). The results also recorded no significant difference 
between male and female in serum level (C4) in all patients figure (4). These results in 
agreement with Castro and Gourley, (2010) in America who founds the Serum levels of 
complement components can serve as markers of disease activity. In immune complex 
deposition disease, serum complement proteins are consumed and serum levels decrease. 
Immune complex disease results from the deposition of antigen-antibody complexes in 
involved organ tissues. In immune complex glomerulonephritis in SLE, decreased C3 and C4 
indicate increased consumption and indicate disease activity. In contrast, increases of C3and 
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C4 indicate inflammatory disorders as these proteins are also acute phase reactants, and 
demonstrated Comprehensive laboratory evaluation of a suspected autoimmune illness in 
conjunction with a thorough clinical evaluation provides a better understanding of a patient's 
immunologic disease. The results of the current study also coincided with other studies in Iran 
showed serum complement levels in 53 patients with various liver diseases. The total serum 
complement level, C4 and C3 was raised in 28, normal in 12 and low in 13 patients ( Fatemeh 
et al., 2010)                                                                                
These results are in agreement with what were found by Porta, (2000) who found 
Complement concentrations, particularly C4, may be low, with levels Much lower in type 2 
when compared to type 1 autoimmune hepatitis; C3 may be low in both types. 
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